The Clorox Company (CLX)
Slow GrowerFairStock Score: 65/100 — STEADY
Key Financials
| Current Price | $89.90 |
| Market Cap | $10.9B |
| P/E Ratio | 18.69 |
| ROE | 163.76% |
| Dividend Yield | 6.02% |
| Sector | Consumer Defensive |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
I approach Clorox as a consumer-defensive business with familiar cleaning and disinfecting brands, but the numbers demand caution. At the 2026-10-26 close of $86.76 and a $10.5B market cap, FairStock calculates a P/E of 18.04 and a P/B of 117.24. That book-value multiple tells me reported equity is tiny, so the 163.76% ROE is not a simple quality signal; ROCE is only 8.32%. Debt/equity of 22.21 is not alarming, but Piotroski 3/9 and Altman Z 1.11 suggest financial health is weak. The growth record is the real problem: FairStock's Lynch category is SLOW GROWER — Shrinking, based on profit falling 2.9% a year over five years and revenue rising 1.1%; it also reports revenue growth of -2.01% and profit growth of -50.90%. Filed results show fiscal year 2025, the year ended 2025-06-30, revenue of $7.1B and net income of $810.0M, EPS $6.52, versus fiscal year 2024, the year ended 2024-06-30, net income of $280.0M and EPS $2.25, and fiscal year 2023, the year ended 2023-06-30, revenue of $7.4B, net income of $149.0M and EPS $1.20, so profit has been volatile while sales stagnated. In fiscal Q3 2026, the quarter ended 2026-03-31, revenue was $1.7B, net income $187.0M and EPS $1.54, only slightly better than fiscal Q3 2025, the quarter ended 2025-03-31, net income of $186.0M and EPS $1.50. Valuation looks stretched on asset value: FairStock's Graham Number is $8.95 versus the $86.76 price, a -865.36% margin of safety, and PEG is 33.26. The 6.02% dividend yield is attractive, but with $405.0M FCF against a $10.5B cap, coverage deserves scrutiny. I see a decent brand franchise, not a bargain.
In plain English: Clorox makes cleaning and disinfecting products, laundry additives, and professional cleaning supplies sold around the world. The business has steady sales but weak recent profit trends and mixed financial-health signals. At $86.76, the shares look expensive compared with the company's reported accounting value and recent earnings, even though the dividend payout is high.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-10-26 close · note generated 2026-10-28 · model deepseek-flash
Sources (SEC EDGAR): fiscal Q3 2026 10-Q (period ended 2026-03-31) · fiscal Q2 2026 10-Q (period ended 2025-12-31) · fiscal Q1 2026 10-Q (period ended 2025-09-30) · fiscal Q3 2025 10-Q (period ended 2025-03-31) · FY2025 10-K (period ended 2025-06-30) · FY2024 10-K (period ended 2024-06-30) · FY2023 10-K (period ended 2023-06-30)
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer